Precigen Inc. (NASDAQ:PGEN) saw an upside of 4.31% to $1.21 after adding $0.05 on Wednesday. The 5-day average trading volume is 1,149,603 shares of the company’s common stock. It has gained $1.3200 in the past week and touched a new high 2 times within the past 5 days. An average of 1,250,626 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 1,302,726.
PGEN’s 1-month performance is 4.31% or $0.0850 on its low of $1.0600 reached on 08/07/23. The company’s shares have touched a 52-week low of $0.81 and high of $2.90, with the stock’s rally to the 52-week high happening on 01/23/23. YTD, PGEN has lost -20.39% or -$0.3250 and has reached a new high 10 times. However, the current price is down -58.28% from the 52-week high price.
Insider Transactions
PGEN stock investors last saw insider trading activity on Aug 04.Sabzevari Helen (President and CEO) most recently sold 52,870 shares at $1.10 per share on Aug 04. This transaction cost the insider $58,157. Chief Legal Officer, Lehr Donald P., sold 10,821 shares at a price of $1.20 on Aug 03. Then, on Aug 03, SVP, IP Affairs Perez Jeffrey Thomas sold 8,789 shares at a price of $1.20 per share. This transaction amounted to $10,547.
Valuation Metrics
PGEN stock has a beta of 1.95. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 13.44 while the price-to-book (PB) in the most recent quarter is 1.51.
In terms of profitability, the gross margin trailing 12 months is 73.50%. The trailing 12-month EBITDA margin is -250.53%. The firm’s gross profit as reported stood at $20.57 million against revenue of $26.91 million.
Earnings Surprise
For the quarterly period ending March 30 this year, Precigen Inc.’s cash and short-term investments amounted to $94.35 million against total debt of $21.69 million. Net income and sales went up compared to those figures reported in the previous quarter. Net income grew 15.31% to -$22.73 million, while revenue of -$22.18 million was 2.42% off the previous quarter. Analysts expected PGEN to announce -$0.09 per share in earnings in its latest quarter, but it posted -$0.1, representing a -11.10% surprise. EBITDA for the quarter stood at more than -$21.94 million. PGEN stock balance sheet for the quarter ending March 30 shows that total liabilities totaled 57.41 million, with total debt at $21.69 million. Shareholders hold equity totaling $255.48 million.
Let’s look briefly at Precigen Inc. (PGEN) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 08 August was 47.11% to suggest the stock is trending Neutral, with historical volatility in this time period at 87.11%.
The stock’s 5-day moving average is $1.1450, reflecting a -0.42% or -$0.0050 change from its current price. PGEN is currently trading +3.02% above its 20-day SMA, +10.65% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by -2.05% and SMA200 by-30.52%.
Stochastic %K and %D was 26.33% and 16.59% and the average true range (ATR) pointed at 0.1008. The RSI (14) points at 48.02%, while the 14-day stochastic is at 36.00% with the period’s ATR at 0.0988. The stock’s 9-day MACD Oscillator is pointing at -0.0556 and -0.0750 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for Precigen Inc. (NASDAQ: PGEN), JP Morgan launched coverage with a Neutral rating. Analysts offering their rating for PGEN stock have a consensus rating for the stock as Buy. Currently, 0 brokerage advisors rate PGEN as a “sell,”, while 1 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 4 have offered a “buy” rating.
What is PGEN’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $6.00 and a high of $14.00, with their median price target at $8.15. Looking at these predictions, the average price target given by analysts is for Precigen Inc. (PGEN) stock is $9.07.
